Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Excelsis Structural Solutions is a specialized contract research organization (CRO) that provides advanced structural characterization services to the pharmaceutical, chemical, and food industries. The company leverages synchrotron-based high-resolution powder X-ray diffraction (HR-PXRD) to offer unprecedented detail in the analysis of drug substances and products. Their services are critical for identifying crystalline phases, determining crystallinity levels, and characterizing amorphous solid dispersions, which are essential for ensuring drug stability and regulatory compliance. Operating out of Switzerland and Belgium, Excelsis works closely with major synchrotron facilities like the Swiss Light Source to support pharmaceutical R&D and manufacturing quality control.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EXCELSIS.